Mary R. Hole

FDA investigator

Appears on 7 documents from 2013 to 2017, mostly at sites in California. Most often cites design controls (21 CFR 820.30).

7
Documents on file
9.0
Observations per 483
2013
First seen
2017
Most recent

What they cite most

From 62 observations

Activity by year

2013: 1, 2015: 4, 2016: 1, 2017: 1

Where

California 7

Is Mary R. Hole coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 UCP Bioscicnces, IncMar 17, 2017 · San Jose, California
483 Helio USA IncJul 6, 2016 · San Jose, California
483 Theranos, Inc.Sep 16, 2015 · Newark, California
483 Affymetrix, IncJul 29, 2015 · Santa Clara, California
483 Helio USA Inc.May 12, 2015 · San Jose, California
483 The Medicines CompanyApr 17, 2015 · Redwood City, California
483 Intuitive Surgical, Inc.May 30, 2013 · Sunnyvale, California

About this profile

What does Mary R. Hole inspect?

Mary R. Hole appears on 7 documents on file covering 6 sites, mostly in California.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 820.100 and 21 CFR 820.198(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Mary R. Hole is dated Mar 17, 2017.